Millennium Labs Expands Tests to Personalize Psychiatric Treatments | GenomeWeb

Millennium Laboratories announced this week that it has enhanced its Urine Drug Testing platform to gauge the presence of commonly prescribed mental health drugs. Additionally, Millennium also expanded its Pharmacogenetic Testing platforms to gauge additional genetic markers that predict whether psychiatric patients will respond to various medications.

Previously both platforms were used to personalized treatments for patients suffering from pain.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.